430 related articles for article (PubMed ID: 27379544)
1. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
[TBL] [Abstract][Full Text] [Related]
2. Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors.
Savaridas SL; Taylor DB; Gunawardana D; Phillips M
Clin Radiol; 2017 Dec; 72(12):1085.e1-1085.e9. PubMed ID: 28870431
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
Karimi Z; Phillips J; Slanetz P; Lotfi P; Dialani V; Karimova J; Mehta T
AJR Am J Roentgenol; 2021 Feb; 216(2):340-348. PubMed ID: 32755162
[No Abstract] [Full Text] [Related]
4. Background Parenchymal Enhancement at Contrast-Enhanced Spectral Mammography (CESM) as a Breast Cancer Risk Factor.
Sorin V; Yagil Y; Shalmon A; Gotlieb M; Faermann R; Halshtok-Neiman O; Sklair-Levy M
Acad Radiol; 2020 Sep; 27(9):1234-1240. PubMed ID: 31812577
[TBL] [Abstract][Full Text] [Related]
5. Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?
Dontchos BN; Rahbar H; Partridge SC; Korde LA; Lam DL; Scheel JR; Peacock S; Lehman CD
Radiology; 2015 Aug; 276(2):371-80. PubMed ID: 25965809
[TBL] [Abstract][Full Text] [Related]
6. Inter- and intrareader agreement for categorization of background parenchymal enhancement at baseline and after training.
Melsaether A; McDermott M; Gupta D; Pysarenko K; Shaylor SD; Moy L
AJR Am J Roentgenol; 2014 Jul; 203(1):209-15. PubMed ID: 24951217
[TBL] [Abstract][Full Text] [Related]
7. Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.
King V; Goldfarb SB; Brooks JD; Sung JS; Nulsen BF; Jozefara JE; Pike MC; Dickler MN; Morris EA
Radiology; 2012 Sep; 264(3):670-8. PubMed ID: 22771878
[TBL] [Abstract][Full Text] [Related]
8. Background parenchymal enhancement at breast MR imaging and breast cancer risk.
King V; Brooks JD; Bernstein JL; Reiner AS; Pike MC; Morris EA
Radiology; 2011 Jul; 260(1):50-60. PubMed ID: 21493794
[TBL] [Abstract][Full Text] [Related]
9. Newly Diagnosed Breast Cancer: Comparison of Contrast-enhanced Spectral Mammography and Breast MR Imaging in the Evaluation of Extent of Disease.
Lee-Felker SA; Tekchandani L; Thomas M; Gupta E; Andrews-Tang D; Roth A; Sayre J; Rahbar G
Radiology; 2017 Nov; 285(2):389-400. PubMed ID: 28654337
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy.
Kim EJ; Kang BJ; Kim SH; Youn IK; Baek JE; Lee HS
Radiology; 2017 Sep; 284(3):656-666. PubMed ID: 28419815
[TBL] [Abstract][Full Text] [Related]
11. Comparison of background parenchymal enhancement (BPE) on contrast-enhanced cone-beam breast CT (CE-CBBCT) and breast MRI.
Ma Y; Liu A; Zhang Y; Zhu Y; Wang Y; Zhao M; Liang Z; Qu Z; Yin L; Lu H; Ye Z
Eur Radiol; 2022 Aug; 32(8):5773-5782. PubMed ID: 35320411
[TBL] [Abstract][Full Text] [Related]
12. Pilot study of quantitative analysis of background enhancement on breast MR images: association with menstrual cycle and mammographic breast density.
Scaranelo AM; Carrillo MC; Fleming R; Jacks LM; Kulkarni SR; Crystal P
Radiology; 2013 Jun; 267(3):692-700. PubMed ID: 23418005
[TBL] [Abstract][Full Text] [Related]
13. MRI background parenchymal enhancement, fibroglandular tissue, and mammographic breast density in patients with invasive lobular breast cancer on adjuvant endocrine hormonal treatment: associations with survival.
Lo Gullo R; Daimiel I; Rossi Saccarelli C; Bitencourt A; Sevilimedu V; Martinez DF; Jochelson MS; Morris EA; Reiner JS; Pinker K
Breast Cancer Res; 2020 Aug; 22(1):93. PubMed ID: 32819432
[TBL] [Abstract][Full Text] [Related]
14. Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.
Arasu VA; Miglioretti DL; Sprague BL; Alsheik NH; Buist DSM; Henderson LM; Herschorn SD; Lee JM; Onega T; Rauscher GH; Wernli KJ; Lehman CD; Kerlikowske K
J Clin Oncol; 2019 Apr; 37(12):954-963. PubMed ID: 30625040
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
Sung JS; Stamler S; Brooks J; Kaplan J; Huang T; Dershaw DD; Lee CH; Morris EA; Comstock CE
Radiology; 2016 Sep; 280(3):716-22. PubMed ID: 27097237
[TBL] [Abstract][Full Text] [Related]
16. Background parenchymal enhancement assessment: Inter- and intra-rater reliability across breast MRI sequences.
Bignotti B; Calabrese M; Signori A; Tosto S; Valdora F; Tagliafico A; Durando M; Mariscotti G
Eur J Radiol; 2019 May; 114():57-61. PubMed ID: 31005177
[TBL] [Abstract][Full Text] [Related]
17. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.
Ray KM; Kerlikowske K; Lobach IV; Hofmann MB; Greenwood HI; Arasu VA; Hylton NM; Joe BN
Radiology; 2018 Mar; 286(3):822-829. PubMed ID: 29072981
[TBL] [Abstract][Full Text] [Related]
18. Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer.
Wu S; Berg WA; Zuley ML; Kurland BF; Jankowitz RC; Nishikawa R; Gur D; Sumkin JH
Breast Cancer Res; 2016 Jul; 18(1):76. PubMed ID: 27449059
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of background parenchymal enhancement (BPE) on breast MRI. A feasibility study with a semi-automatic and automatic software compared to observer-based scores.
Tagliafico A; Bignotti B; Tagliafico G; Tosto S; Signori A; Calabrese M
Br J Radiol; 2015; 88(1056):20150417. PubMed ID: 26462852
[TBL] [Abstract][Full Text] [Related]
20. Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging.
Ko KH; Jung HK; Kim I
Medicine (Baltimore); 2017 Aug; 96(33):e7850. PubMed ID: 28816987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
